INTRODUCTION
============

The increase in cross-sectional imaging studies in the last decades has made possible early detection of renal tumors. These achievements have propelled the Nephron Sparing Surgery (NSS) as the gold standard in the treatment of Stage T1 renal tumors ([@B1]-[@B3]). Such procedures do not imply in a significant increase in the postoperative morbidity with some discussions about the oncological results. Although EORTC group published in 2011 level 1 evidence against NSS in terms of survival, limitations of the study (recognized even by authors) and other publications showed comparable outcomes between radical and conservative renal surgeries ([@B4]-[@B6]).

Minimally invasive surgical techniques has changed the treatment paradigm of patients with RCC stage T1. Literature is contradictive concerning the rate of positive surgical margins (PSM) considering the surgical approach. While some authors suggest that Laparoscopic Partial Nephrectomy (LPN) and robot-assisted partial nephrectomy present higher rates of PSM in comparison to Open Partial Nephrectomy (OPN) ([@B7]) others deny such difference ([@B8]).

The aim of this study is to evaluate the association of PSM with local and distant recurrence and describe the clinical and pathological characteristics that can predict recurrence in those patients with PSM and clinical stage T1.

MATERIALS AND METHODS
=====================

This is a retrospective cohort study including patients with pT1 renal cell carcinoma that underwent NSS either by open or minimally invasive surgery (laparoscopic or robot-assisted), from January 2010 to June 2015 at the Hospital Italiano de Buenos Aires, Argentina. Three possible surgical techniques were used based on tumor location: enucleation (resection of the tumor only); polar nephrectomy (resection of the entire pole including single or multiple lesions) or hemi-nephrectomy (half of the kidney was resected including single or multiple lesions). Enucleation was the first choice whenever possible (exophytic lesions without sinus involvement). Minimally invasive and open NSS technique have been previously described ([@B9], [@B10]). Data was collected prospectively from the electronic clinical history. Demographic data and the clinical pathological characteristics as well as the follow-up registry were tabulated: gender, body mass index (BMI), tumor size, approach, histologic sub-classification, Fuhrman grade, PSM and clinical situation at the last follow-up (no recurrence, local recurrence, distant recurrence or death by cancer). Pathology exam data was detailed according to the sixth edition of the American Joint Committee on Cancer (AJCC) TNM ([@B11]). The nuclear grade was informed based on the Fuhrman classification ([@B12]). A computed tomography (CT) scan of the chest, abdomen and pelvis with intravenous contrast was performed for staging the tumor.

The surgical approach was registered (open, minimally invasive). All the resected pieces were revised by the same pathologist experienced in oncological urology. A positive margin was assigned to the tumor cell that contacted with chinese ink.

The oncologic follow-up was performed according to the NCCN guidelines ([@B13]).

Local recurrence was defined as a tumor mass in the ipsilateral kidney over the resection bed of the same histological type of the original tumor.

Patients older than 18 years of age with single renal tumors pT1a and pT1b with a minimum follow-up of three months were included.

Patients with multiple and/or bilateral tumors, metastases at the time of diagnosis, benign tumors or hereditary renal tumors (Von Hippel Lindau), were excluded.

The presence of PSM or NSM was registered. Both populations were compared and the oncologic results were analysed according to local or distant recurrence.

Statistical analysis
--------------------

Continuous normally distributed variables are expressed by their mean and standard deviation. Not normally distributed variables are expressed as medians and their interquartile (IQR) ranges and categorical variables are expressed as n (%). To compare the continuous variables with normal distribution we used the T-test. In case of not normally distribution we utilized the Mann-Whitney test. To compare the categorical variables we used the Chi-square or Fisher test if the assumption for the first was not complied. For the estimation of disease-free survival (DFS) we used the method of Kaplan Meier expressed in estimated time and its confidence interval of 95% (95% CI). In the case of comparing subgroups, the log rank test was used. For the estimation of risk in the univariable or multivariable analysis, we used the Cox regression, expressing the hazard ratio (HR) and 95% CI. In Cox multivariable models, cases with not informed Fuhrman grade were dropped. To avoid collinearity with stage (more important for us), we did not include tumor diameter in multivariable analysis. Statistical significance was considered to be at p\<0.05. Analyses were performed using SPSS 18.0^®^.

The present study was approved by the Institutional Ethics Committee after the protocol\'s revision and the procedures used according to international regulations (CEPI 3028).

RESULTS
=======

In the period between January 2010 and June 2015, 347 NSS surgeries were performed in patients with pT1. Of all the studied patients, 314 met the inclusion criteria. There were 22 PSM (9 open, 12 laparoscopic and 1 robot-assisted), the rate of PSM for open, laparoscopic and robotic assisted approach was 6.3%, 5% and 7.9%, respectively (p=0.673). [Table-1](#t1){ref-type="table"} shows no difference in baseline characteristics between groups by margin status. The minimally invasive approach was used in 172 (54.8%) patients, 20 of which were operated with robotic assistance. Clear cell carcinoma was the most common histologic type followed by chromophobe and papillary with no statistical difference in PSM (6.1%, 11.1%, and 10% respectively, p=0.79). The median follow-up was 24 months (IQR 12-40).

###### Baseline characteristics.

                               Total          NSM            PSM           p
  ---------------------------- -------------- -------------- ------------- ----------
  No. pts (%)                  314            292 (93)       22 (7)        
  Male (%)                     218 (69.4)     202 (69.2)     16 (72.7)     0.72
  Mean Age (SD)                58.3 (12)      58.2 (12.2)    58.9 (14.8)   0.81
  Mean BMI (SD)                28.2 (4.8)     28.2 (4.7)     28.6 (4.8)    0.67
  **Approach (%)**                                                         **0.67**
  Open                         142 (45.2)     133 (45.5)     9 (40.9)      
  Minimally Invasive           172 (54.8)     159 (54.5)     13 (59.1)     
  Median tumor size mm (IQR)   29.7 (21-38)   30 (21.2-38)   27 (20-30)    0.51
  **Histology (%)**                                                        **0.92**
  Clear-cell                   245 (78)       230 (78.8)     15 (68.2)     
  Chromophobe                  45 (14.3)      40 (13.7)      5 (22.7)      
  Papillary type I             10 (3.2)       9 (3.1)        1 (4.5)       
  Papillary type II            10 (3.2)       9 (3.1)        1 (4.5)       
  Other                        4 (1.3)        4 (1.3)        0 (0)         
  **Fuhrman (%)**                                                          **0.62**
  Non informed                 49 (15.6)      44 (15.1)      5 (22.3)      
  Grade I y II                 258 (82.2)     242 (82.9)     16 (72.7)     
  Grade III y IV               7 (2.2)        6 (2)          1 (4.5)       
  **Tumor Stage (%)**                                                      **0.82**
  pT1a                         266 (84.7)     247 (84.6)     19 (86.4)     
  pT1b                         48 (15.3)      45 (15.4)      3 (13.6)      

During follow-up, local recurrence rate was 1.9% (6 patients). In PSM group we found 2 (9.1%) local recurrences both with synchronic distant metastases. In the NSM group there were 4 local recurrences (1.4%), 2 with synchronic distant metastases. Six patients, all in the NSM group, presented with distant metastases alone.

The estimated local recurrence-free survival (LRFS) rate at 3 years for the NSM group was 96.4% (CI 91.9-100), while for the PSM group was 87.8% (95% CI 71.9-100), with a statistically significant difference (log rank test p=0.02; [Figure-1](#f1){ref-type="fig"}). The estimated metastasis-free survival (MFS) rate at 3 years in patients with PSM was 87.8% (95% CI 71.9-100) and for those who had NSM was 95.4% (95% CI .92, 1-98.7), with no significant difference (p=0.127 log rank test). Only 1 patient died of disease progression at 12 months (pT1b, Fuhrman II, NSM).
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The estimated 3 year LRFS and MFS for Fuhrman III-IV was 66.7% and 50% respectively, in contrast to 98.1% and 95.2% in Fuhrman I-II (p=0.0001).

PSM and Fuhrman grade III or IV were independent predictors of LRFS, while stage, age, tumor size and type of approach didn\'t result as predictors ([Table-2](#t2){ref-type="table"}). High Fuhrman grade and tumor stage were the only factors that increased the risk of metastases ([Table-3](#t3){ref-type="table"}). For multivariable analysis, cases without Fuhrman informed (i.e., chromophobe) were dropped out, thus cohort analysed included 265 patients.

###### Univariable and multivariable analysis of local recurrence.

                                         Univariable       Multivariable                                                         
  ------------------- ------------------ ----------------- ---------------------------------- ---------------------------------- -------
  **PSM**             7.3 (1.33-40.2)    0.023             7.7 (1.3-47)                       0.026                              
  **Age**             1.01 (0.94-1.08)   0.718             1.02 (0.9-1.1)                     0.601                              
  **Tumor size mm**   1.01 (0.94-1.08)   0.701             [++](#TFN1){ref-type="table-fn"}   [++](#TFN1){ref-type="table-fn"}   
  **Fuhrman**                                                                                                                    
                      Grade I-II         Ref.                                                 Ref.                               
                      Grade III-IV       20.3 (3.7-110)    0.001                              16.3 (1.9-135)                     0.01
  **Stage**                                                                                                                      
                      pT1a               Ref.                                                 Ref.                               
                      pT1b               2.5 (0.47-13.9)   0.28                               0.8 (0.1-7.7)                      0.861
  **Approach**                                                                                                                   
                      Laparoscopic       Ref.                                                 Ref.                               
                      Open               0.4 (0.08-2.5)    0.36                               0.5 (0.08-4.1)                     0.578

Excluded to avoid collinearity with Stage.

###### Univariable and multivariable analysis of distant recurrence.

                                         Univariable       Multivariable                                                         
  ------------------- ------------------ ----------------- ---------------------------------- ---------------------------------- -------
  **PSM**             3.7 (0.8-17.7)     0.09              3.5 (0.7-17)                       0.127                              
  **Age**             1.03 (0.9-1.1)     0.305             1.03 (0.9-1.1)                     0.266                              
  **Tumor size mm**   1.08 (1.04-1.14)   0.0001            [++](#TFN2){ref-type="table-fn"}   [++](#TFN2){ref-type="table-fn"}   
  **Fuhrman**                                                                                                                    
                      Grade I-II         Ref.                                                 Ref                                
                      Grade III-IV       19.5 (5-75.8)     0.001                              9.4 (2.1-43)                       0.004
  **Stage**                                                                                                                      
                      pT1a               Ref.                                                 Ref.                               
                      pT1b               8.23 (2.3-29.2)   0.001                              5.2 (1.2-22)                       0.026
  **Approach**                                                                                                                   
                      Laparoscopic       Ref.                                                 Ref.                               
                      Open               0.35 (0.09-1.3)   0.129                              0.9 (0.2-4.4)                      0.902

Excluded to avoid collinearity with Stage

The presence of local recurrence in the univari able analysis shows an increased risk of distant recurrence with a HR 33.4 (95% CI 9.3119, p=0.0001).

The PSM rate for group Fuhrman I-II and III-IV was 6.2% and 14.3%, respectively with no positive association (p=0.367).

DISCUSSION
==========

Trends in NSS are rising around the world, although there are some concerns about the sig-nificance of PSM in terms of oncological outcomes ([@B14], [@B15]). Nowadays incidental renal tumors are frequently found and suitable for NSS ([@B16], [@B17]). In this study, we evaluated the association between PSM and local or distant recurrence in patients with pT1 renal tumors undergoing NSS.

Several studies highlight the impact of PSM on recurrence free survival ([@B14], [@B15], [@B18]-[@B27]). Shah et al. recently reported in a large retrospective cohort of patients undergoing partial nephrectomy for localized renal tumors, that some patients with high risk disease (eg pT2-pT3a or Fuhrman grade II-III) with PSM will experience relapse with distant metastasis ([@B28]). As well as some authors ([@B22], [@B28]) we found that PSM was independently associated with local recurrence, but not directly linked with distant recurrence. This relationship was observed in higher Fuhrman grade (III and IV), but we didn\'t demonstrated increased risk in T1b tumors (over T1a). We didn\'t analyse histological type because our high prevalence of clear cell histology.

A multicentric retrospective study comparing 111 patients with PSM and 664 patients with NSM, concluded that patients with PSM presented a higher risk of local recurrence, even though there were no statistically significant differences in recurrence-free survival, cancer-specific sur-vival and overall survival ([@B14]). In relation to this work, the Memorial Sloan Kettering Cancer Center ([@B20]) analysed 777 PN between 1989 and 2005. Of 75 patients who had PSM (7.5%), only 2 developed local recurrence (4%), while from 713 patients (92; 5%) with NSM, 4 presented recurrence (0.5%). They concluded that patients with PSM have a higher incidence of local recurrence, not determined by the margin status. A bibliographic review of 3.803 RCC and 173 PSM concluded that a positive margin in PN rarely correlates with local recurrence ([@B15], [@B20]-[@B23]). Khalifeh et al. ([@B24]) published a total of 943 robot-assisted PNs; 21 patients (2.2%) had PSM and 922 had NSM. When comparing both groups, they concluded that PSM had higher rates of local recurrence and metastases (p\<0.001) in relation to NSM and that there was a statistically significant difference in the recurrence-free survival and metastasis between the two groups (log rank test \<0.001). PSM presented 18.4 more times the risk for recurrence in the multivariate study. Patients with PSM present worse oncological prognosis, higher probabilities of local recurrence of the disease (log rank test p=0.02) and perhaps more likely to have distant re-currence (although without significant difference, log rank test p=0.127). An interesting fact is that local recurrence increases the risk of metastasis (HR 33.4), which highlights the importance of determining the risk of local recurrence itself.

It is debatable to analyse recurrence without inform cancer specific survival that is the principal global oncologic outcome, even with PSM. Reports that underestimate the value of PSM, may incur in a bias in the truly effect of PSM in cancer survival.

It is controversial what to do with PSM. Although the American Urological Association and the National Comprehensive Cancer Network guidelines do not recognize the clinical significance of PSM, in view of our results it seems reasonable to follow-up all patients but with close surveillance imaging ([@B28]). Nephrectomy or repeat resection remains unnecessary with no study demonstrating clear advantages. Several studies observed that PSM not necessarily signify residual disease. Benalash et al. observed residual disease in only 39% of patients with PSM who underwent repeat surgery ([@B14]).

In agreement with other authors, we found that the rate of positive margins is comparable between open and minimally invasive surgery, for the path does not predispose to risk of recurrence ([@B27], [@B29]).

Although we have not routinely performed intra-operative frozen sections, its relevance grows as a PSM seems to impact in local relapse. Unfortunately, many authors suggest that intraoperative frozen section has limited utility. Arguments against the routine use of frozen section in NSS, are that it has a relatively high false-negative rate and inconsistency in changing intra-operative management ([@B30]).

This study presents some limitations. It is a retrospective study of a single center, so the results could be sensitive to selection bias. The low incidence of positive surgical margins and the relative infrequency of pathologically aggressive lesions treated with NSS explain the low number of events that lead us to wide HR confidence intervals that may limit the interpretations of our findings, despite significance, so caution must be taken in the results interpretation. On the other hand, finding this level of increased risk with this number of events is unlikely to happen by chance bias.

Based on the outcomes of uni/multivariable analysis and Kaplan Meier curves adjusted by grade and PSM, recurrences are more likely to happen in the first two years and not proportional with time, but follow-up is too short to ensure the proportional model.

CONCLUSIONS
===========

PSM in NSS for pT1 tumors has a lower local recurrence-free estimated survival compared to patients with NSM. Fuhrman grade is another predictor of disease free survival. The relationship between PSM and Fuhrman grade should be studied to ensure that the complete resection of the tumor should not be underestimated. However, larger series of patients and longer follow-up time is needed to draw more accurate conclusions.
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